Treating gestational trophoblastic disease

Bibliography

• Bagshawe KD. Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-85
   PubMed Web of Science ®Google Scholar
• Goldstein DP, Berkowitz RS. Gestational trophoblastic neoplasms: clinical principles of diagnosis and management (Major problems in obstetrics and gynecology). (volume 14). Saunders, Philadelphia; 1982. p. xvi, 1301
   Google Scholar
• Lurain JR. Advances in management of high-risk gestational trophoblastic tumors. J Reprod Med 2002;47:451-9
   PubMed Web of Science ®Google Scholar
• Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean experience. J Reprod Med 1998;43:60-8
   PubMed Web of Science ®Google Scholar
• Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med 1996;335:1740-8
   PubMed Web of Science ®Google Scholar
• Elias KM, Goldstein D, Berkowitz R. Complete hydatidiform mole in women older than age 50. J Reprod Med 2010;55:208-12
   PubMed Web of Science ®Google Scholar
• Feltmate CM, Batorfi J, Fulop V, Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol 2003;101:732-6
   PubMed Web of Science ®Google Scholar
• Wolfberg AJ, Feltmate C, Goldstein DP, Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy. Obstet Gynecol 2004;104:551-4
   PubMed Web of Science ®Google Scholar
• Wolfberg AJ, Growdon WB, Feltmate CM, Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Obstet Gynecol 2006;108:393-6
   PubMed Web of Science ®Google Scholar
• Lavie I, Rao GG, Castrillon DH, Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles. Am J Obstet Gynecol 2005;192:1362-4
   PubMed Web of Science ®Google Scholar
• Kashimura Y, Kashimura M, Sugimori H, Prophylactic chemotherapy for hydatidiform mole. Five to 15 years follow-up. Cancer 1986;58:624-9
   PubMed Web of Science ®Google Scholar
• Goldstein DP, Berkowitz RS. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol 1995;22:157-60
   PubMed Web of Science ®Google Scholar
• Kim DS, Moon H, Kim KT, Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol 1986;67:690-4
   PubMed Web of Science ®Google Scholar
• Limpongsanurak S. Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med 2001;46:110-16
   PubMed Web of Science ®Google Scholar
• Kohorn EI. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. J Reprod Med 2002;47:445-50
   PubMed Web of Science ®Google Scholar
• McGrath S, Short D, Harvey R, The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1). Br J Cancer 2010;102:810-14
   PubMed Web of Science ®Google Scholar
• Hammond CB, Weed JC Jr, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980;136:844-58
   PubMed Web of Science ®Google Scholar
• Lurain JR, Singh DK, Schink JC. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med 2006;51:773-6
   PubMed Web of Science ®Google Scholar
• Mutch DG, Soper JT, Baker ME, Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1986;68:348-52
   PubMed Web of Science ®Google Scholar
• Garner EI, Garrett A, Goldstein D, Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. J Reprod Med 2004;49:411-14
   PubMed Web of Science ®Google Scholar
• Dhillon T, Palmieri C, Sebire NJ, Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia. J Reprod Med 2006;51:879-87
   PubMed Web of Science ®Google Scholar
• Bagshawe KD, Harland S. Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer 1976;38:112-18
   PubMed Web of Science ®Google Scholar
• Bakri Y, al-Hawashim N, Berkowitz R. CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor. J Reprod Med 2000;45:94-6
   PubMed Web of Science ®Google Scholar
• Berkowitz RS, Goldstein DP. Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Annu 1981;11:391-411
   PubMedGoogle Scholar
• Bagshawe KD, Noble MI. Cardio-respiratory aspects of trophoblastic tumours. Q J Med 1966;35:39-54
   PubMedGoogle Scholar
• Jones WB, Wagner-Reiss KM, Lewis JL Jr. Intracerebral choriocarcinoma. Gynecol Oncol 1990;38:234-43
   PubMed Web of Science ®Google Scholar
• Bakri Y, Berkowitz RS, Goldstein DP, Brain metastases of gestational trophoblastic tumor. J Reprod Med 1994;39:179-84
   PubMed Web of Science ®Google Scholar
• Cagayan MS, Lu-Lasala LR. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: a 12-year review at the Philippine General Hospital. J Reprod Med 2006;51:785-92
   PubMed Web of Science ®Google Scholar
• Athanassiou A, Begent RH, Newlands ES, Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital. Cancer 1983;52:1728-35
   PubMed Web of Science ®Google Scholar
• Liu TL, Deppe G, Chang QT, Cerebral metastatic choriocarcinoma in the People's Republic of China. Gynecol Oncol 1983;15:166-70
   PubMed Web of Science ®Google Scholar
• Bakri YN, Subhi J, Amer M, Liver metastases of gestational trophoblastic tumor. Gynecol Oncol 1993;48:110-13
   PubMed Web of Science ®Google Scholar
• Berkowitz RS, Goldstein DP, Bernstein MR. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986;23:111-18
   PubMed Web of Science ®Google Scholar
• Growdon WB, Wolfberg AJ, Goldstein DP, Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol 2009;112:353-7
   PubMed Web of Science ®Google Scholar
• Homesley HD. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease. J Reprod Med 1998;43:69-74
   PubMed Web of Science ®Google Scholar
• Osathanondh R, Goldstein DP, Pastorfide GB. Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer 1975;36:863-6
   PubMed Web of Science ®Google Scholar
• Bagshawe KD, Dent J, Newlands ES, The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 1989;96:795-802
   PubMedGoogle Scholar
• Lurain JR. Treatment of gestational trophoblastic tumors. Curr Treat Options Oncol 2002;3:113-24
   PubMedGoogle Scholar
• Osborne R, Gerulath A. What is the best regimen for low-risk gestational trophoblastic neoplasia? A review. J Reprod Med 2004;49:602-16
   PubMed Web of Science ®Google Scholar
• Petrilli ES, Twiggs LB, Blessing JA, Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group. Cancer 1987;60:2173-6
   PubMed Web of Science ®Google Scholar
• Fulop V, Szigetvari I, Szepesi J, 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. J Reprod Med 2010;55:253-7
   PubMed Web of Science ®Google Scholar
• Roberts JP, Lurain JR. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996;174:1917-23; discussion 1923-4
   PubMed Web of Science ®Google Scholar
• Rose PG, Piver MS. Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease. J Surg Oncol 1989;41:148-52
   PubMed Web of Science ®Google Scholar
• Osborne R, Filiaci VL, Schink JC, A randomized phase III trial comparing weekly parenteral methotrexate and pulsed dactinomycin as primary management of low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group Study. Gynecol Oncol 2008;108:s2
   Web of Science ®Google Scholar
• Cole LA, Khanlian SA, Muller CY, Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 2006;102:160-4
   PubMed Web of Science ®Google Scholar
• Feltmate CM, Genest DR, Goldstein DP, Advances in the understanding of placental site trophoblastic tumor. J Reprod Med 2002;47:337-41
   PubMed Web of Science ®Google Scholar
• Papadopoulos AJ, Foskett M, Seckl MJ, Twenty-five years' clinical experience with placental site trophoblastic tumors. J Reprod Med 2002;47:460-4
   PubMed Web of Science ®Google Scholar
• Palmer JE, Macdonald M, Wells M, Epithelioid trophoblastic tumor: a review of the literature. J Reprod Med 2008;53:465-75
   PubMed Web of Science ®Google Scholar
• Rustin GJ, Newlands ES, Lutz JM, Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 1996;14:2769-73
   PubMed Web of Science ®Google Scholar
• Rojas-Espaillat L, Houck KL, Hernandez E, Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report. J Reprod Med 2007;52:431-4
   PubMed Web of Science ®Google Scholar
• Kim SJ, Bae SN, Kim JH, Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 1998;71:247-53
   PubMed Web of Science ®Google Scholar
• Curry SL, Blessing JA, DiSaia PJ, A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in ‘poor prognosis’ metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. Obstet Gynecol 1989;73:357-62
   PubMed Web of Science ®Google Scholar
• DuBeshter B, Berkowitz RS, Goldstein DP, Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol 1987;69:390-5
   PubMed Web of Science ®Google Scholar
• Gordon AN, Gershenson DM, Copeland LJ, High-risk metastatic gestational trophoblastic disease: further stratification into two clinical entities. Gynecol Oncol 1989;34:54-6
   PubMed Web of Science ®Google Scholar
• Bolis G, Bonazzi C, Landoni F, EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol 1988;31:439-44
   PubMed Web of Science ®Google Scholar
• Bower M, Newlands ES, Holden L, EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-43
   PubMed Web of Science ®Google Scholar
• Kim SJ, Bae SN, Kim JH, Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT – 25 years experiences of KRI-TRD. Int J Gynaecol Obstet 1998;60(Suppl 1):S85-96
   Google Scholar
• Xiang Y, Sun Z, Wan X, EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. J Reprod Med 2004;49:443-6
   PubMed Web of Science ®Google Scholar
• Bagshawe KD. Treatment of high-risk choriocarcinoma. J Reprod Med 1984;29:813-20
   PubMed Web of Science ®Google Scholar
• Lurain JR, Singh DK, Schink JC. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med 2006;51:767-72
   PubMed Web of Science ®Google Scholar
• Soper JT, Evans AC, Clarke-Pearson DL, Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol 1994;83:113-17
   PubMed Web of Science ®Google Scholar
• Willemse PH, Aalders JG, Bouma J, Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin. Obstet Gynecol 1988;71:438-40
   PubMed Web of Science ®Google Scholar
• Lotz JP, Andre T, Donsimoni R, High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer 1995;75:874-85
   PubMed Web of Science ®Google Scholar
• Piamsomboon S, Kudelka AP, Termrungruanglert W, Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature. Eur J Gynaecol Oncol 1997;18:453-6
   PubMed Web of Science ®Google Scholar
• Lurain JR, Nejad B. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97:618-23
   PubMed Web of Science ®Google Scholar
• Wang J, Short D, Sebire NJ, Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann Oncol 2008;19:1578-83
   PubMed Web of Science ®Google Scholar
• Clark RM, Nevadunsky N, Ghosh S, The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med 2010;55:194-8
   PubMed Web of Science ®Google Scholar
• Tse KY, Chan KK, Tam KF, 20-year experience of managing profuse bleeding in gestational trophoblastic disease. J Reprod Med 2007;52:397-401
   PubMed Web of Science ®Google Scholar
• Yingna S, Yang X, Xiuyu Y, Clinical characteristics and treatment of gestational trophoblastic tumor with vaginal metastasis. Gynecol Oncol 2002;84:416-19
   PubMed Web of Science ®Google Scholar
• Soper JT. Surgical therapy for gestational trophoblastic disease. J Reprod Med 1994;39:168-74
   PubMed Web of Science ®Google Scholar
• Yang J, Xiang Y, Wan X, The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment. Gynecol Oncol 2006;103:479-82
   PubMed Web of Science ®Google Scholar
• Tomoda Y, Arii Y, Kaseki S, Surgical indications for resection in pulmonary metastasis of choriocarcinoma. Cancer 1980;46:2723-30
   PubMed Web of Science ®Google Scholar
• Fleming EL, Garrett L, Growdon WB, The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med 2008;53:493-8
   PubMed Web of Science ®Google Scholar
• Edwards JL, Makey AR, Bagshawe KD. The role of thoracotomy in the management of the pulmonary metastases of gestational choriocarcinoma. Clin Oncol 1975;1:329-39
   PubMedGoogle Scholar
• Shirley RL, Goldstein DP, Collins JJ Jr. The role of thoracotomy in the management of patients with chest metastases from gestational trophoblastic disease. J Thorac Cardiovasc Surg 1972;63:545-50
   PubMed Web of Science ®Google Scholar
• Wang YA, Song HZ, Xia ZF, Drug resistant pulmonary choriocarcinoma metastasis treated by lobectomy: report of 29 cases. Chin Med J (Engl) 1980;93:758-66
   PubMed Web of Science ®Google Scholar
• Sink JD, Hammond CB, Young WG Jr. Pulmonary resection in the management of metastases from gestational choriocarcinoma. J Thorac Cardiovasc Surg 1981;81:830-4
   PubMed Web of Science ®Google Scholar
• Lehman E, Gershenson DM, Burke TW, Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol 1994;12:2737-42
   PubMed Web of Science ®Google Scholar
• Newlands ES, Holden L, Seckl MJ, Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J Reprod Med 2002;47:465-71
   PubMed Web of Science ®Google Scholar
• Newlands ES, Bagshawe KD, Begent RH, Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol 1991;98:550-7
   PubMedGoogle Scholar
• Evans AC Jr, Soper JT, Clarke-Pearson DL, Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol 1995;59:226-30
   PubMed Web of Science ®Google Scholar
• Brace K. The role of irradiation in the treatment of metastatic trophoblastic disease. Radiology 1968;91:540-4
   Web of Science ®Google Scholar
• Yordan EL Jr, Schlaerth J, Gaddis O, Radiation therapy in the management of gestational choriocarcinoma metastatic to the central nervous system. Obstet Gynecol 1987;69:627-30
   PubMed Web of Science ®Google Scholar
• Grumbine FC, Rosenshein NB, Brereton HD, Management of liver metastasis from gestational trophoblastic neoplasia. Am J Obstet Gynecol 1980;137:959-61
   PubMed Web of Science ®Google Scholar
• Wong LC, Choo YC, Ma HK. Hepatic metastases in gestational trophoblastic disease. Obstet Gynecol 1986;67:107-11
   PubMed Web of Science ®Google Scholar
• Jones WB, Schneider J, Shapiro F, Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. Gynecol Oncol 1996;61:126-30
   PubMed Web of Science ®Google Scholar
• Sutton GP, Soper JT, Blessing JA, Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Am J Obstet Gynecol 1992;167:489-95
   PubMed Web of Science ®Google Scholar
• Osborne R, Covens A, Mirchandani D, Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet. J Reprod Med 2004;49:655-61
   PubMed Web of Science ®Google Scholar
• Wan X, Yang X, Xiang Y, Floxuridine-containing regimens in the treatment of gestational trophoblastic tumor. J Reprod Med 2004;49:453-6
   PubMed Web of Science ®Google Scholar
• Matsui H, Iitsuka Y, Suzuka K, Salvage chemotherapy for high-risk gestational trophoblastic tumor. J Reprod Med 2004;49:438-42
   PubMed Web of Science ®Google Scholar
• Gordon AN, Kavanagh JJ, Gershenson DM, Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease. Cancer 1986;58:1407-10
   PubMed Web of Science ®Google Scholar
• DuBeshter B, Berkowitz RS, Goldstein DP, Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med 1989;34:189-92
   PubMed Web of Science ®Google Scholar
• Azab M, Droz JP, Theodore C, Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors. Cancer 1989;64:1829-32
   PubMed Web of Science ®Google Scholar
• Giacalone PL, Benos P, Donnadio D, High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. Gynecol Oncol 1995;58:383-5
   PubMed Web of Science ®Google Scholar
• van Besien K, Verschraegen C, Mehra R, Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue. Gynecol Oncol 1997;65:366-9
   PubMed Web of Science ®Google Scholar
• Cole LA. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease. J Reprod Med 1998;43:3-10
   PubMed Web of Science ®Google Scholar
• Cole LA, Kohorn EI, Kim GS. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels. J Reprod Med 1994;39:193-200
   PubMed Web of Science ®Google Scholar
• Cole LA, Butler S. Detection of hCG in trophoblastic disease. The USA hCG reference service experience. J Reprod Med 2002;47:433-44
   PubMed Web of Science ®Google Scholar
• Hancock BW. hCG measurement in gestational trophoblastic neoplasia: a critical appraisal. J Reprod Med 2006;51:859-60
   PubMed Web of Science ®Google Scholar
• Mitchell H, Bagshawe KD, Newlands E, Importance of accurate human chorionic gonadotropin measurement in the treatment of gestational trophoblastic disease and testicular cancer. J Reprod Med 2006;51:868-70
   PubMed Web of Science ®Google Scholar
• Cole LA, Kohorn EI. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.J Reprod Med 2006;51:793-811
   PubMed Web of Science ®Google Scholar
• Kohorn EI. What we know about low-level hCG: definition, classification and management. J Reprod Med 2004;49:433-7
   PubMed Web of Science ®Google Scholar
• Hwang D, Hancock BW. Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases. J Reprod Med 2004;49:559-62
   PubMed Web of Science ®Google Scholar
• Khanlian SA, Cole LA. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin. J Reprod Med 2006;51:812-18
   PubMed Web of Science ®Google Scholar
• Mutch DG, Soper JT, Babcock CJ, Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center. Cancer 1990;66:978-82
   PubMed Web of Science ®Google Scholar
• Goldstein DP, Zanten-Przybysz IV, Bernstein MR, Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. J Reprod Med 1998;43:37-43
   PubMed Web of Science ®Google Scholar
• Ngan HY, Tam KF, Lam KW, Relapsed gestational trophoblastic neoplasia: a 20-year experience. J Reprod Med 2006;51:829-34
   PubMed Web of Science ®Google Scholar
• Garrett LA, Garner EI, Feltmate CM, Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med 2008;53:481-6
   PubMed Web of Science ®Google Scholar
• Ayhan A, Ergeneli MH, Yuce K, Pregnancy after chemotherapy for gestational trophoblastic disease. J Reprod Med 1990;35:522-4
   PubMed Web of Science ®Google Scholar
• Kim JH, Park DC, Bae SN, Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol 1998;71:108-12
   PubMed Web of Science ®Google Scholar
• Kjer JJ, Iversen T. Malignant trophoblastic tumours in Norway. Fertility rate after chemotherapy. Br J Obstet Gynaecol 1990;97:623-5
   Google Scholar
• Kobayashi O, Matsui H, Takamizawa H. Analysis of pregnancy outcome after chemotherapy of trophoblastic disease. Nippon Sanka Fujinka Gakkai Zasshi 1986;38:181-6
   PubMedGoogle Scholar
• Ngan HY, Wong LC, Ma HK. Reproductive performance of patients with gestational trophoblastic disease in Hong Kong. Acta Obstet Gynecol Scand 1988;67:11-14
   PubMed Web of Science ®Google Scholar
• Song HZ, Wu PC, Wang YE, Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up. Am J Obstet Gynecol 1988;158:538-45
   PubMed Web of Science ®Google Scholar
• Van Thiel DH, Ross GT, Lipsett MB. Pregnancies after chemotherapy of trophoblastic neoplasms. Science 1970;169:1326-7
   PubMed Web of Science ®Google Scholar
• Woolas RP, Bower M, Newlands ES, Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynaecol 1998;105:1032-5
   PubMedGoogle Scholar
• Matsui H, Iitsuka Y, Suzuka K, Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor. J Reprod Med 2004;49:531-4
   PubMed Web of Science ®Google Scholar
• Wenzel L, Berkowitz R, Robinson S, The psychological, social, and sexual consequences of gestational trophoblastic disease. Gynecol Oncol 1992;46:74-81
   PubMed Web of Science ®Google Scholar
• Petersen RW, Ung K, Holland C, The impact of molar pregnancy on psychological symptomatology, sexual function, and quality of life. Gynecol Oncol 2005;97:535-42
   PubMed Web of Science ®Google Scholar
• Wenzel L, Berkowitz RS, Newlands E, Quality of life after gestational trophoblastic disease. J Reprod Med 2002;47:387-94
   PubMed Web of Science ®Google Scholar
• Wenzel L, Berkowitz RS, Habbal R, Predictors of quality of life among long-term survivors of gestational trophoblastic disease. J Reprod Med 2004;49:589-94
   PubMed Web of Science ®Google Scholar